Improving immunity to Haemophilus influenzae in children with chronic suppurative lung disease

Vaccine

Volumn 33, Issue 2, 2015, Pages 321-326

  Pizzutto, Susan J ^a   Yerkovich, Stephanie T ^a,b,c   Upham, John W ^c,d   Hales, Belinda J ^e   Thomas, Wayne R ^e   Chang, Anne B ^a,f  

^a MENZIES SCHOOL OF HEALTH RESEARCH   (Australia)

^b THE PRINCE CHARLES HOSPITAL   (Australia)

^c UNIVERSITY OF QUEENSLAND   (Australia)

^d PRINCESS ALEXANDRA HOSPITAL   (Australia)

^e UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^f ROYAL CHILDREN'S HOSPITAL   (Australia)

Author keywords

Cell mediated immune response; Non CF bronchiectasis; Non typeable Haemophilus influenzae; Pneumococcal H. influenzae protein D conjugate vaccine

Indexed keywords

GAMMA INTERFERON; HAEMOPHILUS INFLUENZAE VACCINE; IMMUNOGLOBULIN G1; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 5; PNEUMOCOCCUS VACCINE; RECOMBINANT PROTEIN; RECOMBINANT PROTEIN D; UNCLASSIFIED DRUG; BACTERIAL PROTEIN; BACTERIUM ANTIBODY; CARRIER PROTEIN; CYTOKINE; GLPQ PROTEIN, HAEMOPHILUS INFLUENZAE; IMMUNOGLOBULIN D; IMMUNOGLOBULIN G; LIPOPROTEIN; PHID-CV VACCINE; VACCINE;

ADOLESCENT; ADULT; ARTICLE; BACTERIAL IMMUNITY; CELLULAR IMMUNITY; CHILD; CHRONIC LUNG DISEASE; CHRONIC SUPPURATIVE LUNG DISEASE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RESPONSE; FEMALE; HAEMOPHILUS INFECTION; HAEMOPHILUS INFLUENZAE; HUMAN; HUMAN CELL; IMMUNOGLOBULIN BLOOD LEVEL; IN VITRO STUDY; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; VACCINATION; AUSTRALIA; BIOSYNTHESIS; BLOOD; BRONCHIECTASIS; CHRONIC DISEASE; COMPLICATION; IMMUNIZATION; IMMUNOLOGY; INFANT; LUNG DISEASE; PRESCHOOL CHILD;

ANTIBODIES, BACTERIAL; BACTERIAL PROTEINS; BRONCHIECTASIS; CARRIER PROTEINS; CHILD; CHILD, PRESCHOOL; CHRONIC DISEASE; CYTOKINES; FEMALE; HAEMOPHILUS INFLUENZAE; HUMANS; IMMUNIZATION, SECONDARY; IMMUNOGLOBULIN D; IMMUNOGLOBULIN G; INFANT; INTERFERON-GAMMA; INTERLEUKIN-13; INTERLEUKIN-5; LIPOPROTEINS; LUNG DISEASES; MALE; NORTHERN TERRITORY; PNEUMOCOCCAL VACCINES; VACCINATION; VACCINES, CONJUGATE;

EID: 84922357332     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2014.11.024     Document Type: Article

References (32)

1. Murphy T.F., Faden H., Bakaletz L.O., Kyd J.M., Forsgren A., Campos J., et al. Nontypeable Haemophilus influenzae as a pathogen in children. Pediatr Infect Dis J 2009, 28:43-48.
2. Kapur N., Grimwood K., Masters I.B., Morris P.S., Chang A.B. Lower airway microbiology and cellularity in children with newly diagnosed non-CF bronchiectasis. Pediatr Pulmonol 2012, 47(3):300-307.
3. Wurzel D.F., Marchant J.M., Yerkovich S.T., Upham J.W., Mackay I.M., Masters I.B., et al. Prospective characterisation of protracted bacterial bronchitis (PBB) in children. Chest 2014, 145(6):1271-1278.
4. Zgherea D., Pagala S., Mendiratta M., Marcus M.G., Shelov S.P., Kazachkov M. Bronchoscopic findings in children with chronic wet cough. Pediatrics 2012, 129(2):e364-e369. 10.1542/peds.2011-0805.
5. Smith-Vaughan H.C., Binks M.J., Marsh R.L., Kaestli M., Ward L., Hare K.M., et al. Dominance of Haemophilus influenzae in ear discharge from Indigenous Australian children with acute otitis media with tympanic membrane perforation. BMC Ear Nose Throat Disord 2013, 13(1):12.
6. Stephen A.T., Leach A.J., Morris P.S. Impact of swimming on chronic suppurative otitis media in Aboriginal children: a randomised controlled trial. Med J Aust 2013, 199(1):51-55.
7. Prymula R., Habib A., François N., Borys D., Schuerman L. Immunological memory and nasopharyngeal carriage in 4-year-old children previously primed and boosted with 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) with or without concomitant prophylactic paracetamol. Vaccine 2013, 31(16):2080-2088.
8. Tandon M.K., Phillips M., Waterer G., Dunkley M., Comans P., Clancy R. Oral immunotherapy with inactivated nontypeable Haemophilus influenzae reduces severity of acute exacerbations in severe COPD. Chest 2010, 137(4):805-811.
9. Chang A., Byrnes C., Everard M. Diagnosing and preventing chronic suppurative lung disease (CSLD) and bronchiectasis. Paediatr Respir Rev 2011, 12(2):97-103.
10. Kaur R., Casey J.R., Pichichero M.E. Serum antibody response to three non-typeable Haemophilus influenzae outer membrane proteins during acute otitis media and nasopharyngeal colonization in otitis prone and non-otitis prone children. Vaccine 2011, 29(5):1023-1028.
11. Vesikari T., Wysocki J., Chevallier B., Karvonen A., Czajka H., Arsène J.-P., et al. Immunogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) compared to the licensed 7vCRM vaccine. Pediatr Infect Dis J 2009, 28(4):S66-S76.
12. Novotny L.A., Clements J.D., Bakaletz L.O. Transcutaneous immunization as preventative and therapeutic regimens to protect against experimental otitis media due to nontypeable Haemophilus influenzae. Mucosal Immunol 2011, 4:456-467.
13. Pizzutto S.J., Yerkovich S.T., Upham J.W., Hales B.J., Thomas W.R., Chang A.B. Children with chronic suppurative lung disease have a reduced capacity to synthesize interferon-gamma in vitro in response to non-typeable Haemophilus influenzae. PLOS ONE 2014, 9(8):e104236. 10.1371/journal.pone.0104236.
14. King P.T., Hutchinson P.E., Johnson P.D., Holmes P.W., Freezer N.J., Holdsworth S.R. Adaptive immunity to nontypeable Haemophilus influenzae. Am J Respir Crit Care Med 2003, 167(4):587-592.
15. See S.B., Thomas W.R. Protective anti-outer membrane protein immunity against Pasteurella pneumotropica infection of mice. Microbes Infect 2013, 15(6):470-479.
16. Heaton T., Rowe J., Turner S., Aalberse R.C., de Klerk N., Suriyaarachchi D., et al. An immunoepidemiological approach to asthma: identification of in-vitro T cell response patterns associated with different wheezing phenotypes in children. Lancet 2005, 365(9454):142-149.
17. Prescott S.L., Macaubas C., Smallacombe T., Holt B.J., Sly P.D., Holt P.G. Development of allergen-specific T-cell memory in atopic and normal children. Lancet 1999, 353(9148):196-200.
18. Hales B.J., Chai L.Y., Elliot C.E., Pearce L.J., Zhang G., Heinrich T.K., et al. Antibacterial antibody responses associated with the development of asthma in house dust mite-sensitised and non-sensitised children. Thorax 2012, 67(4):321-327.
19. Hales B.J., Pearce L.J., Kusel M.M.H., Holt P.G., Sly P.D., Thomas W.R. Differences in the antibody response to a mucosal bacterial antigen between allergic and non-allergic children. Thorax 2008, 63(3):221-227.
20. Sharma S.K., Casey J.R., Pichichero M.E. Reduced memory CD4+ T-cell generation in the circulation of young children may contribute to the otitis-prone condition. J Infect Dis 2011, 204(4):645-653.
21. van den Bergh M.R., Biesbroek G., Rossen J.W.A., de Steenhuijsen Piters W.A.A., Bosch A.A.T.M., van Gils E.J.M., et al. associations between pathogens in the upper respiratory tract of young children: interplay between viruses and bacteria. PLOS ONE 2012, 7(10):e47711. 10.1371/journal.pone.0047711.
22. Wiertsema S.P., Corscadden K.J., Mowe E.N., Zhang G., Vijayasekaran S., Coates H.L., et al. IgG responses to pneumococcal and Haemophilus Influenzae protein antigens are not impaired in children with a history of recurrent acute otitis media. PLOS ONE 2012, 7(11):e49061. 10.1371/journal.pone.0049061.
23. Abe Y., Murphy T., Sethi S., Faden H., Dmochowski J., Harabuchi Y., et al. Lymphocyte proliferative response to P6 of Haemophilus influenzae is associated with relative protection from exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2002, 165(7):967-971.
24. Higgs R., Higgins S.C., Ross P.J., Mills K.H.G. Immunity to the respiratory pathogen Bordetella pertussis. Mucosal Immunol 2012, 5:485-5500.
25. Mascart F., Verscheure V., Malfroot A., Hainaut M., Piérard D., Temerman S., et al. Bordetella pertussis infection in 2-month-old infants promotes type 1 t cell responses. J Immunol 2003, 170(3):1504-1509.
26. Meyer C.U., Zepp F., Decker M., Lee M., Chang S.-J., Ward J., et al. Cellular immunity in adolescents and adults following acellular pertussis vaccine administration. Clin Vaccine Immunol 2007, 14(3):288-292.
27. Vermeulen F., Dirix V., Verscheure V., Damis E., Vermeylen D., Locht C., et al. Persistence at one year of age of antigen-induced cellular immune responses in preterm infants vaccinated against whooping cough: comparison of three different vaccines and effect of a booster dose. Vaccine 2013, 31(15):1981-1986.
28. Ross P.J., Sutton C.E., Higgins S., Allen A.C., Walsh K., Misiak A., et al. Relative contribution of Th1 and Th17 cells in adaptive immunity to Bordetella pertussis: towards the rational design of an improved acellular pertussis vaccine. PLoS Pathog 2013, 9(4):e1003264. 10.1371/journal.ppat.1003264.
29. Slinger R., Chan F., Ferris W., Yeung S.W., St Denis M., Gaboury I., et al. Multiple combination antibiotic susceptibility testing of nontypeable Haemophilus influenzae biofilms. Diagn Microbiol Infect Dis 2006, 56(3):247-253.
30. Goodman S.D., Obergfell K.P., Jurcisek J.A., Novotny L.A., Downey J.S., Ayala E.A., et al. Biofilms can be dispersed by focusing the immune system on a common family of bacterial nucleoid-associated proteins. Mucosal Immunol 2011, 4:625-637.
31. Wu S., Baum M.M., Kerwin J., Guerrero D., Webster S., Schaudinn C., et al. Biofilm-specific extracellular matrix proteins of nontypeable Haemophilus influenzae. Pathog Dis 2014, [Epub ahead of print Jun 19]. 10.1111/2049-632X.12195.
32. Marsh R.L., Thornton R.B., Smith-Vaughan H.C., Richmond P., Pizzutto S.J., Chang A.B. Detection of biofilm in bronchoalveolar lavage from children with non-cystic fibrosis bronchiectasis. Pediatr Pulmonol 2014, [Epub ahead of print Mar 18]. 10.1002/ppul.23031.